Convalescent plasma: An unexpected new therapeutic option for critically ill COVID-19 patients coming from the past
J Clin Anesth
.
2024 Jun:94:111411.
doi: 10.1016/j.jclinane.2024.111411.
Epub 2024 Feb 8.
Authors
Massimo Franchini
1
,
Arturo Casadevall
2
,
Mario Cruciani
3
,
Michael J Joyner
4
,
Liise-Anne Pirofski
5
,
Jonathon W Senefeld
6
,
Shmuel Shoham
7
,
David J Sullivan
2
,
Daniele Focosi
8
Affiliations
1
Department of Transfusion Medicine and Hematology, Carlo Poma Hospital, Mantova, Italy. Electronic address:
[email protected]
.
2
Johns Hopkins Bloomberg School of Public Health, Department of Molecular Microbiology and Immunology, Baltimore, MD, USA.
3
Department of Transfusion Medicine and Hematology, Carlo Poma Hospital, Mantova, Italy.
4
Department of Anesthesiology and Perioperative Medicine, Mayo Clinic, Rochester, MN, USA.
5
Division of Infectious Diseases, Albert Einstein College of Medicine and Montefiore Medical Center, Bronx, NY, USA.
6
Department of Kinesiology and Community Healthy, University of Illinois at Urbana-Champaign, Urbana, IL, USA.
7
Division of Infectious Diseases, Johns Hopkins University School of Medicine, Baltimore, MD, United States.
8
North-Western Tuscany Blood Bank, Pisa University Hospital, Italy.
PMID:
38335905
DOI:
10.1016/j.jclinane.2024.111411
No abstract available
Keywords:
COVID-19 convalescent plasma; Mechanically ventilated patients; Mortality.
Publication types
Letter
Comment
MeSH terms
COVID-19 Serotherapy
COVID-19* / therapy
Critical Illness / therapy
Humans
SARS-CoV-2